NCT07414043Recruiting
Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity
391/2025/OssF/AOUBo
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
The study is multicenter and observational, consisting of a cross-sectional phase (V0) in which data will be collected from patients who are offered drug therapy, and a prospective longitudinal phase in which only patients who agree to start drug therapy for obesity will be involved
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 2 Dec 2025
- Start date
- 22 Oct 2025
- Primary completion date
- 30 Jun 2036
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Obesity
- NCT number
- NCT07414043
What you commit to
- Study type: Observational
- Planned participants: 500
- From 22 Oct 2025 to the primary completion date, 30 Jun 2036
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Endocrinopathies associated with obesity (Cushing's syndrome, uncompensated hypothyroidism)
Other
- \- Secondary forms of obesity:
- Hypothalamic obesity (both monogenic and acquired forms);
- Syndromic obesity (e.g., Prader-Willi, Alstrom, Bardet Biedl, etc.);
Who the study is looking for
- Therapeutic indication for taking one of the following drugs for the treatment of obesity: Orlistat, Naltrexone/Bupropion (Mysimba®), Liraglutide (Saxenda®), Semaglutide (Wegovy®), Tirzepatide (Mounjaro®)
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.